Key result
Overweight was associated with the lowest all-cause inpatient mortality among patients with systolic heart failure compared to normal weight (OR 0.49), whereas cachexia was associated with the highest mortality.
Why the study?
Although the obesity paradox has been reported in heart failure, the authors sought to characterize this observation using the largest available inpatient database of adult patients.
Does body weight category affect all-cause inpatient mortality in patients with systolic or diastolic heart failure?
Observational (n=17,428,246)
Yes
Does body weight category affect all-cause inpatient mortality in patients with systolic or diastolic heart failure?
Odds Ratio: 0.49 (95% CI 0.41–0.58)
Absolute Event Rate: 2.56% vs 5.6%
p-value: p=<0.001
In patients with systolic or diastolic heart failure, being overweight or obese is associated with lower inpatient mortality compared to normal weight, whereas cachexia is associated with significantly higher mortality.
Supports obesity paradox in HF inpatients; hypothesis-generating and should not yet change weight management.
Introduction A phenomenon known as the obesity paradox has been reported in patients with heart failure (HF) suggesting lower mortality with increasing weight. The goal of this study is to characterize this observation in HF using the largest available inpatient database of adult patients. Method We searched the National Inpatient Sample (NIS) database for patients for the years 2016-2020 with a diagnosis of systolic (SHF) or diastolic heart failure (DHF) using International Classification of Diseases, Tenth Revision (ICD-10) diagnosis codes. We evaluated mortality association based on body weight. Multivariate statistical analysis was performed to adjust all-cause inpatient mortality for comorbidities. Results There was a total of 7,364,023 patients with a diagnosis of SHF and 10,064,223 patients with a diagnosis of DHF. All-cause inpatient mortality was lowest in overweight patients followed by those with obesity and morbid obesity, whereas mortality was highest in cachexia compared to normal weight for SHF and DHF patients (mortality: overweight 2.56%, obese 3.12%, morbidly obese 3.70%, normal weight 5.60%, and cachexia 15.22%; p<0.001) and DHF patients (mortality: overweight 2.08%, obese 2.43%, morbidly obese 2.93%, normal weight 4.58%, and cachexia 14.25%; p<0.001). This relationship remains similar after multivariate analysis. (SHF patients: overweight OR: 0.49 (0.41-0.58), obesity OR: 0.64 (0.62-0.66), morbid obesity OR: 0.85 (0.83-0.88), and cachexia OR: 2.78 (2.67-2.90); p<0.001; DHF patients: overweight OR: 0.47 (0.40-0.56), obesity OR: 0.61 (0.59-0.63), morbid obesity OR: 0.83 (0.81-0.85), and cachexia OR: 3.09 (2.96-3.23); p<0.001). Conclusion Our data observed that all-cause inpatient mortality in SHF and DHF is lowest in overweight populations followed by obese and morbidly obese populations whereas cachexia has the highest mortality. However, increasing weight above the overweight reduces the obesity paradox benefit.
No takes yet. Share an insight, caveat, or question.
Movahed et al. (2024) conducted an observational in Systolic or diastolic heart failure (n=17,428,246). Overweight vs. Normal weight was evaluated on All-cause inpatient mortality (Systolic Heart Failure group) (OR 0.49, 95% CI 0.41-0.58, p=<0.001). Overweight was associated with the lowest all-cause inpatient mortality among patients with systolic heart failure compared to normal weight (OR 0.49), whereas cachexia was associated with the highest mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: